Neuroendocrine Tumour Education Course

NECA HEADER 1700px HR

How to identify a neuroendocrine cancer when it’s not part of the typical line-up. A RACGP & ACN – CPD accredited course.

Join our patients in an interactive, case based online activity, on how to diagnose and treat Neuroendocrine Tumours (NETs) in General Practice.

4,557 health care professionals around Australia have enrolled in NeuroEndocrine Cancer (NECA) Australia’s FREE Health Care Professionals Education modules. Have you?

By the end of this course, participants will be able to:

  • Discuss the pathophysiology and epidemiology of neuroendocrine tumours (NETs)
  • Outline the symptoms of NETs
  • Describe appropriate investigations and diagnostic pathways for patients with suspected NETs
  • Outline pharmacological and non-pharmacological treatment options for NETs and their appropriate clinical application
  • Using a multidisciplinary team, formulate a whole-person approach to the management of patients with NETs
  • All participants will receive a certificate upon completion.

This course is open to all healthcare professionals with an AHPRA number including GPs, Surgeons, Registrars, Pharmacists, Dermatologists and Specialists.

Enrol Here

Download Flyer

Download Here

Please ensure your printer settings are on ‘Fit to Page’ to print as an A4 document.

Share this event

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related Events

Will Norman Nurse Webinar on Neuroendocrine Cancer 2026

Date: March 20, 2026
Start Time: 7:00 am

Living with NETs – March 2026

Date: March 3, 2026
Start Time: 1:30 pm

Equitable Access to Cancer Care: Reflection on the Senate Inquiry Parliamentary Event

Date: October 30, 2025
Start Time: 3:30 pm

Sydney NET Patient Forum

Date: October 28, 2025
Start Time: 5:30 pm

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.